INES (9742) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
18 May, 2026Executive summary
Net sales for the first nine months ended December 31, 2024, decreased 3.0% year-over-year to ¥28,143 million, with operating profit up 31.8% to ¥1,539 million and profit attributable to owners of parent up 40.8% to ¥998 million.
Public sector sales rose 1.7% due to standardization system introduction, while private sector sales fell 6.5% on lower insurance and retail system project orders.
The company is executing its 2026 Medium-term Management Plan, focusing on local government system standardization, next-generation solutions, and business foundation enhancement.
Financial highlights
Operating profit increased to ¥1,539 million (up 31.8% year-over-year), ordinary profit to ¥1,595 million (up 27.9%), and profit attributable to owners of parent to ¥998 million (up 40.8%).
Comprehensive income for the period was ¥1,109 million, up 23.7% year-over-year.
Gross profit margin improved as cost savings were realized, notably from the absence of prior year facility costs.
Cash flows from operating activities increased to ¥3,184 million, while investing activities used ¥1,293 million and financing activities used ¥1,229 million.
Outlook and guidance
Full-year forecast remains unchanged: net sales of ¥44,000 million (up 8.5% year-over-year), operating profit of ¥4,000 million (up 39.0%), ordinary profit of ¥4,000 million (up 46.4%), and profit attributable to owners of parent of ¥2,700 million (up 50.3%).
Dividend forecast for the fiscal year ending March 31, 2025, is ¥55.00 per share.
Latest events from INES
- Standardization delays drove lower FY2024 guidance as interim earnings weakened; annual dividend forecast rose to ¥50.9742
Q2 2024 - FY2024 revenue fell, but FY2025 guidance points to recovery and a higher dividend.9742
Q4 2024 - Net sales up 12.7% year-over-year, losses narrowed, and dividend forecast raised.9742
Q1 2027 - Q1 FY2025 saw a swing to loss amid lower sales, but full-year outlook and DX investments continue.9742
Q1 2025 - Revenue fell 5.0% while profits rose; FY guidance held and standardization sales shifted later.9742
Q2 2025 - Profit climbed on flat sales, with FY26 growth led by municipal standardization work.9742
Q4 2025 - Sales and profits fell on project delays, but full-year guidance and dividend forecast are maintained.9742
Q1 2026 - Municipal delays and migration costs drove H1 losses and lower FY26 guidance.9742
Q2 2026 - FY26 loss followed standardization charges; FY27 guidance targets a profit recovery.9742
Q4 2026